Literature DB >> 15237859

Physiological roles of xanthine oxidoreductase.

Roger Harrison1.   

Abstract

Xanthine oxidoreductase (XOR) is a major protein component of the milk fat globule membrane (MFGM) surrounding fat droplets in milk and its enzymology is well characterised. The enzyme is widely distributed in mammalian tissues and is generally accepted to be a key enzyme of purine catabolism. It catalyses the oxidation of a wide range of substrates and can pass electrons to molecular oxygen, generating reactive oxygen species (ROS); similar reduction of nitrite yields reactive nitrogen species (RNS). While XOR has been implicated in ischemia-reperfusion injury, its involvement in normal physiological processes has been less studied. It is argued here that XOR-derived ROS and RNS play a role in innate immunity, specifically in the inflammatory response and in anti-microbial defense of the gastrointestinal tract. XOR-derived species could also be involved in signalling. Additionally, XOR is likely to play a part in metabolism of xenobiotics and has recently been shown to mediate the secretion of milk fat globules. The human enzyme has only relatively recently been characterized. The enzyme purified from breast milk shows very low enzymatic activity, and it is suggested that human XOR has evolved so as to be regulated by an exceptional range of pre- and posttranslational mechanisms.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15237859     DOI: 10.1081/dmr-120037569

Source DB:  PubMed          Journal:  Drug Metab Rev        ISSN: 0360-2532            Impact factor:   4.518


  40 in total

1.  Untargeted metabolomics as a diagnostic tool in NAFLD: discrimination of steatosis, steatohepatitis and cirrhosis.

Authors:  Mario Masarone; Jacopo Troisi; Andrea Aglitti; Pietro Torre; Angelo Colucci; Marcello Dallio; Alessandro Federico; Clara Balsano; Marcello Persico
Journal:  Metabolomics       Date:  2021-01-16       Impact factor: 4.290

Review 2.  Single-gene disorders: what role could moonlighting enzymes play?

Authors:  Ganesh Sriram; Julian A Martinez; Edward R B McCabe; James C Liao; Katrina M Dipple
Journal:  Am J Hum Genet       Date:  2005-04-22       Impact factor: 11.025

3.  Butyrophilin controls milk fat globule secretion.

Authors:  Horst Robenek; Oliver Hofnagel; Insa Buers; Stefan Lorkowski; Michael Schnoor; Mirko J Robenek; Hans Heid; David Troyer; Nicholas J Severs
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-26       Impact factor: 11.205

Review 4.  Antimicrobial strategies centered around reactive oxygen species--bactericidal antibiotics, photodynamic therapy, and beyond.

Authors:  Fatma Vatansever; Wanessa C M A de Melo; Pinar Avci; Daniela Vecchio; Magesh Sadasivam; Asheesh Gupta; Rakkiyappan Chandran; Mahdi Karimi; Nivaldo A Parizotto; Rui Yin; George P Tegos; Michael R Hamblin
Journal:  FEMS Microbiol Rev       Date:  2013-07-25       Impact factor: 16.408

5.  The biosynthesis of the molybdenum cofactors.

Authors:  Ralf R Mendel; Silke Leimkühler
Journal:  J Biol Inorg Chem       Date:  2014-07-01       Impact factor: 3.358

Review 6.  The use of microRNAs to modulate redox and immune response to stroke.

Authors:  Yi-Bing Ouyang; Creed M Stary; Robin E White; Rona G Giffard
Journal:  Antioxid Redox Signal       Date:  2015-01-10       Impact factor: 8.401

Review 7.  Reactive oxygen species: key regulators in vascular health and diseases.

Authors:  Qishan Chen; Qiwen Wang; Jianhua Zhu; Qingzhong Xiao; Li Zhang
Journal:  Br J Pharmacol       Date:  2017-07-11       Impact factor: 8.739

8.  The antimicrobial activity of bovine milk xanthine oxidase.

Authors:  Gulustan Ozturk; Ishita M Shah; David A Mills; J Bruce German; Juliana M L N de Moura Bell
Journal:  Int Dairy J       Date:  2019-10-31       Impact factor: 3.032

Review 9.  Cyclic stretch, reactive oxygen species, and vascular remodeling.

Authors:  Konstantin G Birukov
Journal:  Antioxid Redox Signal       Date:  2009-07       Impact factor: 8.401

Review 10.  Nox proteins in signal transduction.

Authors:  David I Brown; Kathy K Griendling
Journal:  Free Radic Biol Med       Date:  2009-07-21       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.